Research graph
References from Hypercoagulability in women with adenomyosis who experience heavy menstrual bleeding. Local targets link to admitted publications; unresolved targets remain external evidence.
The elusive adenomyosis of the uterus--revisited
10.1016/0002-9378(72)90781-8 · 1972 · External reference
Unveiling the pathogenesis of adenomyosis through animal models
2022 · External reference
Adenomyosis: a riddle, wrapped in mystery, inside an enigma
10.1016/j.fertnstert.2021.04.037 · 2021 · External reference
Medical and surgical management of adenomyosis
10.1016/j.bpobgyn.2006.01.012 · 2006 · External reference
The impact of adenomyosis on women's fertility
10.1097/ogx.0000000000000346 · 2016 · External reference
Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis
10.1093/humrep/deu041 · 2014 · External reference
Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis
10.1016/j.fertnstert.2018.01.006 · 2018 · External reference
Adenomyosis: a reappraisal of symptomatology
10.1016/0002-9378(58)90186-8 · 1958 · External reference
Disorders, F.W.G.o.M. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age
10.1016/j.ijgo.2010.11.011 · 2011 · External reference
Physiology of the endometrium and regulation of menstruation
10.1152/physrev.00031.2019 · 2020 · External reference
Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management
10.1016/j.bpobgyn.2016.09.006 · 2017 · External reference
Adenomyosis: the pathophysiology of an oestrogen-dependent disease
10.1016/j.bpobgyn.2006.01.010 · 2006 · External reference
Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp
10.1111/j.1471-0528.1993.tb12986.x · 1993 · External reference
Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?
10.1006/gyno.1995.1188 · 1995 · External reference
Pathology and physiopathology of adenomyosis
10.1016/j.bpobgyn.2006.01.016 · 2006 · External reference
Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist
10.1016/j.fertnstert.2006.09.010 · 2007 · External reference
Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis
10.1093/humrep/16.3.561 · 2001 · External reference
Expression of inflammatory and neurogenic mediators in adenomyosis
10.1177/1933719116657192 · 2017 · External reference
Constitutive and tumor necrosis factor-alpha-induced activation of nuclear factor-kappaB in adenomyosis and its inhibition by andrographolide
10.1016/j.fertnstert.2013.04.028 · 2013 · External reference
Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis
10.1016/j.fertnstert.2009.01.084 · 2009 · External reference
Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent
10.1177/1933719110377118 · 2010 · External reference
Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium
10.1093/humrep/dey015 · 2018 · External reference
Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis
10.1093/humrep/dew018 · 2016 · External reference
Transforming growth factor beta1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice
2016 · External reference
Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence
10.1093/humrep/dev025 · 2015 · External reference
Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation
10.1016/j.mce.2016.03.015 · 2016 · External reference
Cellular changes consistent with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the progression of experimental endometriosis in baboons
10.1177/1933719116641763 · 2016 · External reference
Coagulation and inflammation
10.1177/09680519030090030901 · 2003 · External reference
Further evidence for hypercoagulability in women with ovarian endometriomas
10.1177/1933719118799195 · 2018 · External reference
Evidence for a hypercoagulable state in women with ovarian endometriomas
10.1177/1933719115572478 · 2015 · External reference
Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?
10.1186/s12905-019-0860-9 · 2019 · External reference
Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis
10.1093/humrep/deq311 · 2011 · External reference
Effects of norplant on endometrial tissue factor expression and blood vessel structure
2000 · External reference
Tissue factor and the endometrium: from physiology to pathology
10.1016/j.thromres.2009.06.013 · 2009 · External reference
Immunoreactivity of plasminogen activator inhibitor 1 and its correlation with dysmenorrhea and lesional fibrosis in adenomyosis
10.1007/s43032-021-00513-6 · 2021 · External reference
Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia
10.1016/j.ejogrb.2016.07.499 · 2016 · External reference
Venous thromboembolism and adenomyosis: a retrospective review
10.4103/gmit.gmit_77_19 · 2020 · External reference
Cerebral infarcts by nonbacterial thrombotic endocarditis associated with adenomyosis: a case report
10.1016/j.jstrokecerebrovasdis.2017.10.005 · 2018 · External reference
Cerebral infarcts associated with adenomyosis among middle-aged women
10.1016/j.jstrokecerebrovasdis.2011.10.017 · 2012 · External reference
Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series
10.1186/s12883-018-1213-2 · 2018 · External reference
Acute disseminated intravascular coagulation developed after dilation and curettage in an adenomyosis patient: a case report
10.1097/mbc.0b013e3283641917 · 2013 · External reference
Anemia-associated platelets and plasma prothrombin time increase in patients with adenomyosis
10.3390/jcm11154382 · 2022 · External reference
How does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding?
10.1002/rmb2.12442 · 2022 · External reference
Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy
10.1111/jog.12211 · 2014 · External reference
Submucosal fibroids and the relation to heavy menstrual bleeding and anemia
10.1016/j.ajog.2013.09.038 · 2014 · External reference
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
10.1002/ijgo.12666 · 2018 · External reference
Does menstrual bleeding decrease after ablation of intramural myomas?. A retrospective study
10.1016/j.jmig.2013.05.007 · 2013 · External reference
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group
10.1002/uog.14806 · 2015 · External reference
Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers
10.1016/j.fertnstert.2013.10.051 · 2014 · External reference
Menstrual blood loss--a population study. Variation at different ages and attempts to define normality
10.3109/00016346609158455 · 1966 · External reference
Determination of menstrual blood loss
10.3109/00365516409060511 · 1964 · External reference
Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data
10.1016/j.ajog.2003.11.015 · 2004 · External reference
Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence
10.1186/s12958-016-0198-1 · 2016 · External reference
P-selectin as a potential therapeutic target for endometriosis
10.1016/j.fertnstert.2015.01.001 · 2015 · External reference
Anti-platelet therapy is efficacious in treating endometriosis induced in mouse
10.1016/j.rbmo.2016.07.007 · 2016 · External reference
Endometriosis-derived stromal cells secrete thrombin and thromboxane A2, inducing platelet activation
10.1177/1933719116630428 · 2016 · External reference
Severe adenomyosis and CA125
10.3109/01443615.2013.832178 · 2014 · External reference
High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer
10.1212/01.wnl.0000163850.07976.63 · 2005 · External reference
Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer
10.1097/igc.0b013e31827b8796 · 2013 · External reference
Coagulation testing in the core laboratory
10.1093/labmed/lmx050 · 2017 · External reference
Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism
10.1309/g98j-ana9-rmnc-xlyu · 2000 · External reference
A laboratory evaluation into the short activated partial thromboplastin time
10.1097/mbc.0b013e3283365770 · 2010 · External reference
A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism
10.1182/blood-2004-03-1042 · 2004 · External reference
Unresolved reference
2015 · External reference
On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin
10.1097/00001721-200309000-00012 · 2003 · External reference
Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions
10.1172/jci116947 · 1994 · External reference
The method of in vivo evaluation of hemostasis: spatial thrombodynamics
10.1179/1607845415y.0000000022 · 2015 · External reference
Thrombin alters human endometrial stromal cell differentiation during decidualization
10.1177/1933719118768705 · 2019 · External reference
NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis
10.1074/jbc.m806010200 · 2009 · External reference
Antiplatelet activity of synthetic and natural resveratrol in red wine
1995 · External reference
Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships
10.1007/bf01965408 · 1982 · External reference
Phytochemistry and pharmacology of the genus Leonurus: the herb to benefit the mothers and more
10.1016/j.phytochem.2017.12.016 · 2018 · External reference
Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals
10.4049/jimmunol.1001911 · 2011 · External reference
Danazol treatment and platelet function
10.5694/j.1326-5377.1980.tb134878.x · 1980 · External reference
The retardation of myometrial infiltration, reduction of uterine contractility, and alleviation of generalized hyperalgesia in mice with induced adenomyosis by levo-tetrahydropalmatine (l-THP) and andrographolide
10.1177/1933719111404610 · 2011 · External reference
Resveratrol reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice with induced adenomyosis
10.1177/1933719115572479 · 2015 · External reference
Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis
10.3892/mmr.2017.7238 · 2017 · External reference
Leonurine attenuates hyperalgesia in mice with induced adenomyosis
10.12659/msm.900233 · 2017 · External reference
Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats
10.1177/1933719111424453 · 2012 · External reference
A pilot study on the off-label use of valproic acid to treat adenomyosis
10.1016/j.fertnstert.2006.11.009 · 2008 · External reference
A pilot study on the use of andrographolide to treat symptomatic adenomyosis
10.1016/j.gmit.2014.12.002 · 2014 · External reference
Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device
10.1016/s0015-0282(00)00624-5 · 2000 · External reference
Wound repair at a glance
10.1242/jcs.031187 · 2009 · External reference
Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification
10.1016/j.ajog.2012.06.027 · 2012 · External reference
Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study
10.1097/md.0000000000011457 · 2018 · External reference
